Long-time Slashdot reader theodp writes: As the first COVID-19 vaccines arrived at Penn Medicine last year, Penn Today reported with great pride, “It was mRNA research conducted at Penn—by Drew Weissman, a professor of Infectious Diseases, and Katalin Karikó, an adjunct associate professor—that helped pave the way for the development of the Pfizer-BioNTech and Moderna COVID vaccines.” While Weissman and Karikó…
Tag: infectious diseases
Misleading Viral Claims Show Dangers of Preprint Servers, Researchers Warn
Scientific researchers worry that the capacity for spreading misinformation “goes far beyond the big-name social media sites,” warns the Washington Post. Citing pre-print servers and unvetted “research repositories,” they note that “Any online platform without robust and potentially expensive safeguards is equally vulnerable.” “This is similar to the debate we’re having with Facebook and Twitter. To what degree are we creating…
New strain of Covid-19 explained
A new strain of the virus that causes Covid-19 appears to be spreading fast in the the UK. Why it matters that the coronavirus is changing, and what it means for vaccine effectiveness. Source: https://earthsky.org/human-world/new-strain-of-covid-19-explained…
FDA Approves Pfizer/BioNTech Covid-19 Vaccine For Emergency Use in America
Friday night America’s Food and Drug Administration finally authorized Pfizer and BioNTech’s coronavirus vaccine for emergency use in the United States, reports CNN. The Verge calls it “a landmark moment in the fight to suppress a virus that has killed nearly 300,000 people in the United States and sickened tens of millions around the world.” The vaccine is authorized in the…
Celebrating the Path-Breaking Research That Lead to Coronavirus Vaccines
The Washington Post tells the remarkable story of how both Moderna’s vaccine and the Pfizer/BioNTech vaccine relied on a specially designed spike protein partially created by America’s Vaccine Research Center — along with messenger RNA, “a technology never before harnessed in an approved vaccine.” And also decades of path-breaking research: If, as expected in the next few weeks, regulators give those…
To reduce chances of spreading coronavirus, keep indoor air clean
Being indoors with other people is a recipe for spreading the coronavirus. But removing airborne particles through proper ventilation and air filtration can reduce some of that risk. Source: https://earthsky.org/human-world/keeping-indoor-air-clean-reduce-spread-coronavirus…
Moderna Becomes Second Firm To Reveal Positive Results With Nearly 95% Protection In Trials
An anonymous reader quotes a report from The Guardian: More than 1 billion people could be immunized against coronavirus by the end of next year with shots from the first two companies to reveal positive results, after the latest vaccine was shown to be nearly 95% effective in trials. With the US’s top infectious diseases official, Anthony Fauci, hailing “the light…
Covid-19 will probably become endemic. Here’s what that means
Rather than completely disappear – even when vaccines become available- it’s likely that the coronavirus SARS-CoV-2 will be added to the family of infectious diseases known as “endemic” in the human population. Source: https://earthsky.org/human-world/covid-19-coronavirus-will-probably-become-endemic-defintion…
A Man Caught Coronavirus Twice — and It Was Worse the Second Time
According to a study published in The Lancet Infectious Diseases, a man in the U.S. caught COVID-19 for a second time and had a worse bout of illness. MIT Technology Review reports: The 25-year-old man tested positive for the first time on April 18, after experiencing several weeks of symptoms including sore throat, cough, headache, nausea, and diarrhea. He felt fully…
The Race for a Super-Antibody Against the Coronavirus
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans. From a report: Dozens of companies and academic groups are racing to develop antibody therapies. Already Regeneron and the drug company Eli Lilly have requested emergency use authorizations for their products from the Food…